ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia.

ABSTRACT:

SUBMITTER: Joshi SK 

PROVIDER: S-EPMC7515826 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature